+ Watch ANGO
on My Watchlist
The Company is a provider of innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease and local oncology therapy options for treating cancer.
This is a nice small company that seems to do well competing against larger companies. Their growth rates the last few years along with their quarters show that company is going to stay with us for a while. I like the smaller companies that have a control over their debt. It make them favorable for a possible buy out from a larger company. This is one of these companies that have a low debt to equity ratio. Also the price to book ratio is also quite low. Altogether a good stock for the next year or three.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions